@article{Konstantinopoulos_Giannitsas_Raptis_Perimenis_2007, title={Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives}, volume={2}, url={https://journals.aboutscience.eu/index.php/dti/article/view/1310}, DOI={10.33393/dti.2007.1310}, abstractNote={Endothelial dysfunction is a pathological entity that multiply affects the health status. Erectile dysfunction is being recognized as a condition that is strongly interrelated with endothelial dysfunction, being a vascular event itself. Oral pharmacotherapy for erectile dysfunction has provided us with a new armamentarium on this condition. Phosphodiesterase 5 inhibitors have been investigated and proved useful in clinical practice for erectile dysfunction but in addition to this, the results seem promising of a beneficial effect on endothelial dysfunction, as well.}, number={1}, journal={Drug Target Insights}, author={Konstantinopoulos, Angelis and Giannitsas, Konstantinos and Raptis, Spiros and Perimenis, Petros}, year={2007}, month={Jan.} }